|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0010 - 0.0010|
|52 Week Range||0.0001 - 0.4280|
|Beta (3Y Monthly)||1.97|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cryptobloc Technologies Corp., (“Cryptobloc” or the “Company”) (CSE:CRYP), (CRYBF), (Frankfurt Stock Exchange:GR9) announces that it has successfully been granted a temporary management cease trade order (the “MCTO”) in connection with the anticipated late filing of the Company’s audited annual financial statements (the “Financial Statements”) and management’s discussion and analysis for the financial year ended January 31st, 2019. The Company initially requested the MCTO in order to secure additional time to finalize the Financial Statements.
VANCOUVER, British Columbia, Dec. 27, 2018 -- Cryptobloc Technologies Corp., (“Cryptobloc” or the “Company”) (CSE:CRYP), (OTCMKTS:RGTZF), (Frankfurt Stock Exchange:GR9) is.
VANCOUVER, British Columbia, Dec. 12, 2018 -- Cryptobloc Technologies Corp., (“Cryptobloc” or the “Company”) (CSE:CRYP), (OTC:CRYBF), (FSE:GR9) announces that it will be.
Cryptobloc Technologies Corp. (“Cryptobloc” or the “Company”) (CSE: CRYP, OTC: CRYBF, Frankfurt: GR9) is pleased to announce Corporate Updates. At the request of the Canadian Securities Exchange (the “CSE”) and in furtherance of the Company’s effort to have its shares reinstated for trading, Cryptobloc provides the following background information on the Company’s management team, compensation and an update in respect of the removal of the current trading halt by the CSE on securities of the Company. The Company’s current management team consists of Mr. Rob Abenante (Director and Chief Executive Officer), Kent McParland (Director and Chief Financial Officer) and Cedric (Ric) Wilson (Director).
Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) comments on the news release regarding the British Columbia Securities Commission (“BCSC”) Temporary Order dated November 26, 2018. The BCSC issued a temporary order on Monday, November 26, 2018, which centers around share issuances by 11 CSE issuers to a very large group of consultants between February, 2018, and August, 2018. Abattis has been named as 1 of the 11 issuers as they have ongoing consulting agreements with certain members listed in the group of respondents (the “Respondents”) for services ranging from accounting and finance to marketing. Also, certain of the Respondents participated in an Abattis private placement for $2.25M. For these reasons, Abattis has been named as an issuer in this temporary order.
At the request of the Canadian Securities Exchange (the “CSE”) and in furtherance of the Company’s effort to have its shares reinstated for trading, Cryptobloc provides the following update in respect of the imposition of a trading halt by the CSE on securities of the Company and a general corporate update. The Company’s current management team of Mr. Rob Abenante (Chief Executive Officer) and Kent McParland (Chief Financial Officer) were not involved with and had no relationship with the Company prior to their respective appointments on June 29 and July 4, 2018, and as such disclaim responsibility for any of the Company’s activities prior to those dates. The information provided in this news release has been garnered from trading information and a review of available corporate documentation but not on any personal knowledge of Messrs.